April 7 Review and Insights

The last challenge to the power regulator—Hua Dian Liaoning Energy’s eight-board run—because the pharmaceutical sector is only a transitional theme and doesn’t have especially large room for imagination, so Jin Pharmaceutical shouldn’t be able to reach Hua Dian Liaoning Energy’s standing. The seventh board would be even more dangerous, so the author thinks next Tuesday is the turning point for pharmaceuticals. After the turning point, there are two directions: first, power needs to be strong for a repair. For the repair, we still need to anchor on Hua Dian Liaoning Energy—only once it rises can it pull in some funds to support the repair. The other direction is fiber-optic communication stocks—just at this turning point, continue to raise the stakes and go all out. Huiyuan Communications, Xinneng Taishan, and Zhongli Group. The author thinks Huiyuan Communications will go as a consecutive-limit-up stock, and Zhongli’s low-buy/accumulation on dips should also offer good value. Xinneng Taishan can be used as a reference anchoring stock. Given all this, the author also bought into Zhongli on last Friday on the dip.